The European Medicines Agency (EMA) has green a green signal to GlaxoSmithKline for its once-weekly diabetes drug albiglutide. The Committee for Medicinal Products for Human Use (CHMP) of has recommended in a positive way to the drug which is marketed under the brand name Eperzan. Albiglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is an investigational biological product that … [Read more...]
You are here: Home / Archives for Eperzan